KLP Kapitalforvaltning’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
SL
KLP Kapitalforvaltning's STOK Position: Q3 2026 in Review
KLP Kapitalforvaltning held its Stoke Therapeutics (STOK) position steady in Q3 2026 at 8,800 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.
KLP Kapitalforvaltning first reported a position in STOK in Q4 2024 and has held it in 8 quarters since. The position peaked at $288K in Q2 2026. 125 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- KLP Kapitalforvaltning held 8,800 shares of Stoke Therapeutics worth $229K as of Q3 2026.
- KLP Kapitalforvaltning left its Stoke Therapeutics share count unchanged in Q3 2026.
- Stoke Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1818 holding.
- KLP Kapitalforvaltning first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 8 quarters since.
- KLP Kapitalforvaltning's Stoke Therapeutics position peaked at $288K in Q2 2026.
- 125 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.